MediPharm Labs (TSE:LABS) Trading Up 7.7% – Still a Buy?

MediPharm Labs Corp. (TSE:LABS)’s stock price rose 7.7% during mid-day trading on Tuesday . The company traded as high as C$0.07 and last traded at C$0.07. Approximately 106,847 shares were traded during mid-day trading, a decline of 37% from the average daily volume of 169,924 shares. The stock had previously closed at C$0.07.

MediPharm Labs Price Performance

The company has a current ratio of 3.21, a quick ratio of 3.10 and a debt-to-equity ratio of 1.45. The business has a 50-day moving average price of C$0.07 and a 200 day moving average price of C$0.07. The stock has a market cap of C$29.45 million, a PE ratio of -2.33 and a beta of -0.29.

MediPharm Labs (TSE:LABS) last announced its quarterly earnings data on Thursday, November 13th. The company reported C($0.01) earnings per share for the quarter. The firm had revenue of C$11.45 million during the quarter. MediPharm Labs had a negative return on equity of 24.41% and a negative net margin of 30.56%. As a group, research analysts forecast that MediPharm Labs Corp. will post -0.04 earnings per share for the current fiscal year.

About MediPharm Labs

MediPharm Labs Corp, along with its subsidiaries, produces purified, pharmaceutical-like cannabis extracts and related derivative products. The company generates revenue from Private label, White label, the Tolling process, and others. Some of its vape brands are Northern Lights, Blue Dream Pink Kush and GG4. Its geographical segments are Canada and Australia.